Most medtech leaders in the US and around the globe rate their commercial maturity as only basic to intermediate. A few are racing ahead, outpacing the sector index by eight percentage points of annual shareholder return. What sets them apart? Modernizing the Milkman: AI’s New Playbook for Medtech Commercial Excellence, BCG’s latest medtech commercial study building on more than 15 years of data and insights, shows that AI is the next step in that evolution.
It lays out five concrete moves for how to lead in MedTech Commercial: Continuous prioritization and dynamic targeting, always-on personalized engagement, AI-augmented and autonomous sales, data-driven pricing and margin optimization, and a seamless service experience with 24/7 agents. Discover how leaders are pulling ahead and what it takes to join them.